Background-The mechanism responsible for the reported high incidence of ventricular arrhythmias in mitral valve prolapse is not clear. Electrocardiographic studies show an increased occurrence of repolarisation abnormalities on the 12 lead surface electrocardiogram, indicating regional differences in ventricular recovery. The purpose of this study was to investigate whether dispersion of refractoriness was an arrhythmogenic mechanism. Methods-QT dispersion was measured in 32 patients with echocardiographically documented mitral valve prolapse and ventricular arrhythmias on 24 hour Holter recordings. QT dispersion was defined as the difference between the maximum and minimum average QT interval in any of the 12 leads of the surface electrocardiogram. QT dispersion corrected for heart rate was calculated by Bazett's formula. The results were compared with the data from 32 matched controls without a history of cardiac disease. Patients taking drugs that influence the QT interval and patients with a QRS duration > 120 ms were excluded. Results-QT dispersion was greater in patients with mitral valve prolapse than in matched controls (60 (20) v 39 (11 ms) respectively, P < 0.001) as was corrected QT (64 (20 ms) v 43 (12 ms) respectively, P < 0 001). There was no significant difference in minimum or maximum QT intervals between the two groups. Conclusions-QT dispersion on the 12 lead surface electrocardiogram was greater in patients with mitral valve prolapse with ventricular arrhythmias than in normal controls, but the maximum QT interval was not increased. The results accord with the hypothesis that regional shortening and lengthening of repolarisation times in patients with mitral valve prolapse may account for the increased dispersion of refractoriness. (Br HeartJ' 1995;73:37-40) 
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All 32 patients with mitral valve prolapse had symptoms. Palpitation was the most common indication for Holter monitoring (75%), followed by atypical chest pain (63%), presyncope (34%) and syncope (16%).
The sex and age matched controls were healthy subjects from the surgical day care unit who were examined before general anaesthesia for minor elective surgical procedures. We excluded patients with known disease of the upper abdomen (for example, gallbladder disease, pancreatitis), because these conditions can cause electrocardiographic abnormalities. None of the controls had a history of cardiac disease or arrhythmias, and we excluded controls with ischaemic heart disease, those taking drugs that influence the QT interval, and those with a QRS duration > 120 ms. In total, 32 patients with mitral valve prolapse and 32 controls were selected.
ELECTROCARDIOGRAPHIC MEASUREMENTS
The electrocardiograms of all patients with mitral valve prolapse and controls were analysed by two independent observers (JP and RT) who were not aware of the clinical condition of the patients. The presence of ventricular arrhythmias or STU abnormalities did not interfere with an unbiased measurement. Differences in reading were resolved by consensus. RR, QRS, and QT intervals were measured by hand. QT intervals were measured from the start of the QRS to the end of the T wave, defined as a return to the T-P baseline. When U waves were present the QT was measured to the nadir of the curve between the T and U wave. QT dispersion was determined as described previously. '7-19 Three consecutive cycles were measured in each of the 12 electrocardiogram leads, and a mean QT per lead was calculated from the three values. QT dispersion was defined as the difference between the maximum and minimum QT occurring in any of the 12 electrocardiogram leads. We calculated heart rate corrected QT dispersion (QTc dispersion) using Bazett's formula (QTc = QT interval in milliseconds divided by the square root of RR interval in seconds).2' When there was no definite end to the T wave or interfering premature complexes the lead concerned was not analysed.
In addition, we studied the correlation between the number of ventricular (premature) arrhythmias on 24 hour Holter recordings and QTc dispersion in the patients with mitral valve prolapse. QTc dispersion was calculated in patients with palpitation, collapse, presyncope, or chest pain and compared with QTc dispersion in the total group of patients with mitral valve prolapse.
STATISTICAL ANALYSIS
Data are reported as mean (1 SD). We used the unpaired Student's t test to compare both groups and the Spearman rank-sum test and linear regression analysis for the correlation study. P values <0 05 were regarded as significant.
Results
The table shows the characteristics and electrocardiographic variables of both groups. QT dispersion was significantly greater in the patients with mitral valve prolapse than in the matched controls (P < 0001), even after correction for heart rate. Because the mean number of leads analysed per electrocardiogram was similar in both groups no correction was made for the number of leads analysed.
The incidence of ventricular arrhythmias in the patients with mitral valve prolapse on 24 hour Holter monitoring was classified according to Lown." The median number of premature ventricular complexes was 142/24 hour (range 1-26, 544). Twenty one patients had fewer than 30 premature ventricular complexes/24 hour and 11 had more than 30 premature ventricular complexes/hour. Sixteen patients had couplets of premature ventricular complexes. Non-sustained ventricular tachycardia (heart rate > 100 beats per minute lasting < 30 seconds) was present in 11 patients. There were no patients with sustained ventricular tachycardia or fibrillation.
There was no significant relation between the number of premature ventricular complexes during 24 
Discussion
This study shows that QT and QTc dispersion were higher in patients with mitral valve prolapse and ventricular arrhythmia than in a similar group of controls. In addition, the present report is the first to suggest that this dispersion is the consequence of the combination of short minimum and long maximum QT intervals rather than exclusive QT prolongation. Earlier studies indicated that QTc dispersion reflects underlying regional differences in the recovery of ventricular excitability.'7-'923 Recently, an association has been reported between ventricular arrhythmias and QTc dispersion. 24 Therefore the increased dispersion of refractoriness could well be the arrhythmogenic mechanism in mitral valve prolapse. However, the present study did not detect a direct correlation between the increased dispersion of refractoriness in mitral valve prolapse and the number of spontaneously occurring ventricular arrhythmias or the incidence of complaints such as palpitation, presyncope, or syncope. This could be due to the retrospective design of the study.
There are several possible explanations for increased differences in myocardial recovery times in patients with mitral valve prolapse. One explanation relates to autonomic dysfunction, which is present in most patients with mitral valve prolapse.25 Several studies showed high circulating catecholamines, increased responsiveness to catecholamines, abnormal catecholamine regulation and baroreflex modulation, and activation of atrial natriuretic peptide in patients with mitral valve prolapse. Excitation of the sympathetic nervous system increased dispersion of refractoriness in an animal model both through regional shortening and regional prolongation of ventricular refractoriness. 26 32 The occurrence of adrenergic dependent ventricular arrhythmias also suggests that delayed afterdepolarisations play a part in arrhythmogenesis in mitral valve prolapse. In theory, afterdepolarisations could well be the arrhythmogenic factor in mitral valve prolapse. However, they would cause regional QT prolongation, and although in some earlier electrocardiographic studies the incidence of QTc prolongation in mitral valve prolapse was high,' 4 9 13 we could not demonstrate an increased incidence of prolonged QTc in patients with mitral valve prolapse compared with controls. This accords with other controlled studies.'2 33 Earlier studies' 4 9 13 did not include normal controls. Despite a normal incidence in QTc prolongation, however, we found an increased QTc dispersion, which could serve as an arrhythmogenic mechanism too.
In this study we measured QT intervals in all leads and found that QTc dispersion was increased in patients with ventricular arrhythmias and mitral valve prolapse. Surface electrocardiographic QT measurement may be subject to errors, but variation in interlead measurements far outweighs inaccuracies introduced by any other factor including interobserver variation.2' Our study indicates that increased QT dispersion may be due to regional shortening combined with lengthening of repolarisation times. As outlined above, this shortening of action potential duration may be caused by increased adrenergic stimulation or locally increased wall stress. Other evidence, however, suggests that induction of afterdepolarisations prolongs action potential duration. Therefore, the mechanism of ventricular arrhythmias may vary in different patients with mitral valve prolapse. The fact that ,B blockers can improve symptoms of mitral valve prolapse supports both of the proposed arrhythmogenic mechanisms. fi Blockers prevent the induction of delayed afterdepolarisations in patients with the adrenergic dependent long QT syndrome and also reduce the dispersion of refractoriness. Furthermore, because in our study QTc dispersion was commonly increased in the absence of significant QTc prolongation, there is a new theoretical basis for examining agents, such as class III antiarrhythmic drugs, that reduce dispersion of refractoriness in patients with mitral valve prolapse.
